NCT07082387View on ClinicalTrials.gov

External Oblique and Rectus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
External Oblique and Rectus Abdominis Plane BlockQuadratus Lumborum BlockPostoperative AnalgesiaLaparoscopic Cholecystectomy
Interventions
OTHER

External oblique and rectus abdominis plane block

Patients will receive an external oblique and rectus abdominis plane (EXORA) block using 20ml of bupivacaine 0.25%.

OTHER

Quadratus lumborum block

Patients will receive a quadratus lumborum block (QLB) using 20ml of bupivacaine 0.25%.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07082387 - External Oblique and Rectus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter